Eli Lilly is paying up to $630m for a Phase I MASH candidate from OliX Pharmaceuticals, diversifying its pipeline with an RNA ...

While this condition can be caused by diabetes, tissue disease and neurological disorders, which damage the nerves and blood ...

According to Bank of America, several companies are prime candidates for a stock split in the near future, which could lead ...

Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results ...

Viking Therapeutics is a clinical-stage biotech company focused on developing weight-loss therapies. Read why I rate VKTX ...

Eli Lilly and Company LLY will report its fourth-quarter and full-year 2024 earnings on Feb. 6, before market open. The Zacks ...

We recently compiled a list of the 12 Best Big Name Stocks to Invest in Now. In this article, we are going to take a look at ...

There are many ways to lose weight, but finding the best path can be difficult without assistance. The doctors at Ascension ...

With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...

If your weight loss goals have taken a backward step, this simple device might be all you need to get back on track and shed ...

All products are independently selected by our editors. If you buy something, we may earn an affiliate commission. So you're wondering where to buy sex toys online, since buying in a store isn't ...

Leerink Partners analyst David Risinger maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on January 24 and set a price ...